ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 83

The Risk of Developing Rheumatoid Arthritis Based on HLA-DQ Genotypes

Sami B. Kanaan1, Oyku Sensoy2 and J. Lee Nelson3, 1Clinical Research Division, Fred Hutchinson Cancer Research Center, SEATTLE, WA, 2Clinical Research Division, Fred Hutchinson Cancer Research Center, seattle, WA, 3Fred Hutchinson Cancer Research Center, Seattle, WA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: human leukocyte antigens (HLA), rheumatoid arthritis (RA) and risk

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Session Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The strongest genetic risk for rheumatoid arthritis (RA) is contributed from the HLA region. RA-risk associated HLA-DRB1 alleles including *04:01/4/5/8, *01:01, *10:01, and *14:02 code for the ‘Shared Epitope’ (SE) motif of the DRβ1 third hypervariable region. In an individual’s genotype, different combinations of SE and non-SE alleles contribute differently to RA-risk, as has been delineated in a table of Odds Ratios (OR) in a prior publication (1). Other studies have pointed to the importance in RA of specific DQA1‒DQB1 allele combinations in linkage disequilibrium (LD) with SE alleles that have been referred to as DQ5.1, DQ7.3, and DQ8 (2, 3). Interestingly, these particular DQ molecules, but not other DQs or DRs, bind certain peptides involved in autoantibody-positive RA (3). In the current study we investigated RA risk according to the DQ genotype and evaluated combinations of DQ molecules for hierarchy in RA risk.

Methods: 314 RA patients meeting 1988 ACR criteria and 316 controls from Washington State (USA) and the surrounding area were genotyped for DRB1‒DQA1‒DQB1 haplotypes. DQA1 and DQB1 combinations were classified into 10 groups based on functional relevance and most frequent LD with DRB1: DQ5.1 (LD: DRB1*01), DQ5.2/3 (LD: DRB1*14 and *16), DQ6.1/2 (LD: DRB1*15), DQ6.3/4/5/9 (LD: DRB1*13, RA protective), DQ2 (LD: DRB1*03 and *07, both RA protective), DQ7.3 (LD: DRB1*04), DQ7.5/6 (LD: DRB1*11 and *12), DQ8 (LD: DRB1*04), DQ9 (LD: DRB1*07 and *09), and DQ4 (LD: DRB1*08). ORs for RA-risk were calculated for 48 of 55 possible combinations accounting for 97% of subjects.

Results: The genotypic OR [and 95% confidence intervals] for developing RA based on DQ ranged from 24.9 [4.63‒259.0] to 0.16 [0.04‒0.64]. The risk was generally significant when an individual carried simultaneously 2 of the 3 DQs in linkage with the SE (DQ5.1, DQ7.3 and DQ8), and was alleviated when the second DQ was no longer of those 3. DQ2 provided significant protection when combined with itself, DQ6.3/4/5/9, or DQ7.5/6, which are in linkage with DRB1 alleles previously associated with protection against RA.

Conclusion: The risk of developing RA is influenced by both HLA-DQ alleles in the genotype. ORs varied according to particular combinations of DQ molecules. These observations considered along with recognition that HLA molecules present peptides derived from other (self) HLA molecules point to likely functional significance of HLA-DQ molecules in RA risk.

References:

  1. N. Balandraud et al., PLOS ONE. 8, e64108 (2013).
  2. E. Zanelli, C. J. Krco, J. M. Baisch, S. Cheng, C. S. David, PNAS. 93, 1814–1819 (1996).
  3. J. van Heemst et al., Nature Communications. 6, 6681 (2015).

Funding: This work was supported by NIH grants HL117737 and AI 45659.


Disclosure: S. B. Kanaan, None; O. Sensoy, None; J. L. Nelson, None.

To cite this abstract in AMA style:

Kanaan SB, Sensoy O, Nelson JL. The Risk of Developing Rheumatoid Arthritis Based on HLA-DQ Genotypes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/the-risk-of-developing-rheumatoid-arthritis-based-on-hla-dq-genotypes/. Accessed July 2, 2022.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-risk-of-developing-rheumatoid-arthritis-based-on-hla-dq-genotypes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies